Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013

详细信息    查看全文

• 作者：XueLian Li ; SaiHua Zheng ; ShangJie Chen ; Feng Qin ; Sandy Lau ; Qi Chen
• 关键词：Gynaecological cancer ; Endometrial cancer ; Ovarian cancer ; Cervical cancer ; Age at diagnosis ; China
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：July 2015
• 年：2015
• 卷：36
• 期：7
• 页码：4961-4966
• 全文大小：289 KB
• 参考文献：1.Standards of service provision for gynaecological cancer patients in New Zealand - Provisional., M.o. Health, Editor. National Gynaecological Cancer Tumour Standards Working Group: Wellington; 2013.
  2.Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, et al. National Endometrial Cancer Study, age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176(4):269-8.PubMed Central PubMed View Article
  3.Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2012;21(5):753-0.PubMed View Article
  4.Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev. 2013;22(2):233-1.PubMed View Article
  5.Cook LS, Kmet LM, Magliocco AM, Weiss NS. Endometrial cancer survival among U.S. black and white women by birth cohort. Epidemiology. 2006;17(4):469-2.PubMed View Article
  6.Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97(19):1407.PubMed View Article
  7.Cook LS WN, Doherty JA, Chen C. Endometrial cancer: cancer epidemiology and prevention. New York: Oxford University Press; 2006.View Article
  8.Howlader N, NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975-011, National Cancer Institute. 2014.
  9.Kent A. HPV vaccination and testing. Rev Obstet Gynecol. 2010;3(1):33-.PubMed Central PubMed
  10.Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev. 2014;5:CD010681.PubMed
  11.Armstrong EP. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm. 2010;16(3):217-0.PubMed
  12.Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study. Lancet. 2012;380(9859):2095-28.PubMed View Article
  13.Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-17.PubMed View Article
  14.Gynaecological cancers in Australia: an overview: Australian Institute of Health and Welfare & Cancer Australia. 2012.
  15.Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(21):1625-4.PubMed View Article
  16.Lentz GM, L.R., Gershenson DM, Katz VL. Comprehensive gynecology 6th ed. Neoplastic diseases of the uterus: Mosby. 2013
  17.Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):vi33-.PubMed
  18.Yang D, Haines CJ, Pan P, Zhang Q, Sun Y, Hong S, et al. Menopausal symptoms in mid-life women in southern China. Climacteric. 2008;11(4):329-6.PubMed View Article
  19.Mahdi H, Schlick CJ, Kowk LL, Moslemi-Kebria M, Michener C. Endometrial cancer in Asian and American Indian/Alaskan native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women. Gynecol Oncol. 2014;132(2):443-.PubMed View Article
  20.Ries LAG, YJ, Keel GE, Eisner MP, Lin YD. Horner M-J SEER Survival monograph: cancer survival among adults: U.S. SEER Program, 1988-001, Patient and Tumor Characteristics. National Cancer Institute. Chapter 16: Cancers of the Ovary. 2007.
  
• 作者单位：XueLian Li (1) (2)
  SaiHua Zheng (1)
  ShangJie Chen (1)
  Feng Qin (1)
  Sandy Lau (3)
  Qi Chen (1) (4)
  
  1. The Hospital of Obstetrics and Gynaecology, Fudan University, 419 Fangxie Road, Shanghai, China
  2. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China
  3. Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand
  4. Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

The incidence and the trend of gynaecological cancers have been suggested to vary by ethnicity and geographical regions. Whether the incidence and type of gynaecological cancers in China is different have not been fully investigated. In this study, we reported the trend of gynaecological cancers in China. Data on 13,518 women with gynaecological cancers were collected from the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Data included age at diagnosis and the annual number of women with diagnosed endometrial, ovarian, cervical cancer and other gynaecological cancers. The number of women with diagnosed gynaecological cancers increased by almost sixfold in 2013 compared to that in 2003. It was largely due to the increase of women with newly diagnosed cervical cancer. The percentage of women with endometrial and ovarian cancer within total gynaecological cancers was decreased, whilst the percentage of cervical cancer significantly increased between 2003 and 2013. The mean age of women with endometrial or ovarian cancer at diagnosis was 53 or 48?years, respectively, which was no difference over 11?years. However, the mean age of women with cervical cancer at diagnosis was significantly delayed from 42?years in 2003 to 46?years since 2011. This was also confirmed by the age-specific distribution of gynaecological cancers over 11?years. Our study found that the age onset of endometrial and ovarian cancer has not changed over 11?years. But the age onset of cervical cancer is delayed since 2011 in China.